78/2022. (XII. 28.) BM rendelet
78/2022. (XII. 28.) BM rendelet
az ellenőrzött anyagokról
Az emberi alkalmazásra kerülő gyógyszerekről és egyéb, a gyógyszerpiacot szabályozó törvények módosításáról szóló 2005. évi XCV. törvény 32. § (5a) bekezdésében kapott felhatalmazás alapján,
a 4–6. § tekintetében az emberi alkalmazásra kerülő gyógyszerekről és egyéb, a gyógyszerpiacot szabályozó törvények módosításáról szóló 2005. évi XCV. törvény 32. § (5) bekezdés j) pontjában kapott felhatalmazás alapján,
a Kormány tagjainak feladat- és hatásköréről szóló 182/2022. (V. 24.) Korm. rendelet 66. § (1) bekezdés 26. pontjában meghatározott feladatkörömben eljárva a következőket rendelem el:
1. § (1) Az 1. melléklet tartalmazza a kábítószernek minősülő anyagok jegyzékeit, valamint a kábítószerekkel és pszichotróp anyagokkal, valamint az új pszichoaktív anyagokkal végezhető tevékenységekről, valamint ezen anyagok jegyzékre vételéről és jegyzékeinek módosításáról szóló 66/2012. (IV. 2.) Korm. rendelet 1. § 18. pontja szerinti kábítószertartalmú kivételek jegyzékét.
(2) A 2. melléklet tartalmazza a pszichotróp anyagnak minősülő anyagok jegyzékeit.
(3) A 3. melléklet tartalmazza az új pszichoaktív anyaggá minősített anyagok és vegyületcsoportok jegyzékét.
2. § Ez a rendelet 2023. január 1-jén lép hatályba.
3. § (1) Ez a rendelet
a) az 1-benzilpiperazin (BZP) ellenőrzési intézkedéseknek és büntetőjogi rendelkezéseknek alávetni kívánt, új pszichoaktív anyagként való meghatározásáról szóló, 2008. március 3-i 2008/206/IB tanácsi határozatnak,
b) a 4-metilmetkatinon (mefedron) ellenőrzési intézkedések alá vonásáról szóló, 2010. december 2-i 2010/759/IB tanácsi határozatnak,
c) a 2004/757/IB tanácsi kerethatározatnak a kábítószer fogalommeghatározása új pszichoaktív anyagokkal való kiegészítése céljából történő módosításáról és a 2005/387/IB tanácsi határozat hatályon kívül helyezéséről szóló, 2017. november 15-i (EU) 2017/2103 európai parlamenti és tanácsi irányelvnek,
d) a 2004/757/IB tanácsi kerethatározat mellékletének a kábítószer fogalommeghatározása új pszichoaktív anyagokkal való kiegészítése céljából történő módosításáról szóló, 2018. december 31-i (EU) 2019/369 felhatalmazáson alapuló bizottsági irányelvnek,
e) a 2004/757/IB tanácsi kerethatározat mellékletének a „kábítószer” fogalommeghatározását az N,N-dietil-2-[[4-(1-metiletoxi)fenil]metil]-5-nitro-1H-benzimidazol-1-etánamin (izotonitazén) új pszichoaktív anyaggal kiegészítő módosításáról szóló, 2020. szeptember 2-i (EU) 2020/1687 felhatalmazáson alapuló bizottsági irányelvnek,
f) a 2004/757/IB tanácsi kerethatározat mellékletének a „kábítószer” fogalommeghatározását a metil-3,3-dimetil-2-{[1-(pent-4-én-1-il)–1H-indazol-3-karbonil]amino}butanoát (MDMB-4en-PINACA) és a metil-2-{[1-(4-fluorbutil)–1H-indol-3-karbonil]amino}-3,3-dimetilbutanoát (4F-MDMB-BICA) új pszichoaktív anyaggal kiegészítő módosításáról szóló, 2021. március 12-i (EU) 2021/802 felhatalmazáson alapuló bizottsági irányelvnek,
g) a 2004/757/IB tanácsi kerethatározat mellékletének a „kábítószer” fogalommeghatározását új pszichoaktív anyagokkal kiegészítő módosításáról szóló, 2022. március 18-i (EU) 2022/1326 felhatalmazáson alapuló bizottsági irányelvnek
való megfelelést szolgálja.
(2) Ez a rendelet
a) a 4-metilamfetamin ellenőrzési intézkedéseknek történő alávetéséről szóló, 2013. március 7-i 2013/129/EU tanácsi határozat,
b) az 5-(2-amino-propil)indol ellenőrzési intézkedések alá vonásáról szóló, 2013. október 7-i 2013/496/EU tanácsi határozat,
c) a 4-jód-2,5-dimetoxi-N-(2-metoxi-benzil)fenetilamin (25I-NBOMe), a 3,4-diklór-N-[[1-(dimetil-amino)ciklohexil] metil]benzamid (AH-7921), a 3,4-metilén-dioxi-pirovaleron (MDPV) és a 2-(3-metoxi-fenil)-2-(etil-amino) ciklohexanon (metoxetamin) ellenőrzési intézkedések alá vonásáról szóló, 2014. szeptember 25-i 2014/688/EU tanácsi határozat,
d) a 4-metil-5-(4-metil-fenil)-4,5-dihidrooxazol-2-amin (4,4’-DMAR) és az 1-ciklohexil-4-(1,2-difenil-etil)piperazin (MT-45) ellenőrzési intézkedések alá vonásáról szóló, 2015. október 8-i 2015/1873/EU tanácsi határozat,
e) az N-fenil-N-[1-(2-fenil-etil)piperidin-4-il]ciklopropán-karboxamid (ciklopropil-fentanil) és a 2-me-toxi-N-fenil-N-[1-(2-feniletil)piperidin-4-yl]acetamid (metoxiacetil-fentanil) új pszichoaktív anyagok ellenőrzési intézkedéseknek való alávetéséről szóló, 2018. szeptember 28-i (EU) 2018/1463 tanácsi végrehajtási határozat
végrehajtásához szükséges rendelkezéseket állapít meg.
4. §1
5. §2
6. §3
7. §4
1. melléklet a 78/2022. (XII. 28.) BM rendelethez
|
A |
B |
C |
---|---|---|---|
1 |
Hivatalos név |
Más név vagy rövidítés, külföldön gyakran használt írásmód |
Kémiai név / Leírás |
2 |
3-methylfentanyl* |
N-(3-methyl-1-phenethyl-4-piperidyl)propionanilide |
|
3 |
3-methylthiofentanyl* |
N-[3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
|
4 |
4-fluoroisobutyrfentanyl |
4-FIBF, pFIBF |
N-(4-fluorophenyl)-N-(1-phenetylpiperidin-4-yl)isobutyramide |
5 |
Acetorphine* |
3-O-acetyltetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine (derivative of thebaine) |
|
6 |
Acetyl-alpha-methylfentanyl* |
N-[1-(α-methylphenethyl)-4-piperidyl]acetanilide |
|
7 |
Acetylfentanyl* |
Desmethyl fentanyl |
N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]acetamide |
8 |
Acetylmethadol |
3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
|
9 |
Acryloylfentanyl |
Acrylfentanyl |
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide |
10 |
Alfentanil |
N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenylpropanamide |
|
11 |
Alphacetylmethadol |
α-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
|
12 |
Alphameprodine |
α-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine |
|
13 |
Alphamethadol |
α-6-dimethylamino-4,4-diphenyl-3-heptanol |
|
14 |
Alpha-methylfentanyl* |
N-[1-(α-methylphenethyl)-4-piperidyl]propionanilide |
|
15 |
Alpha-methylthiofentanyl* |
N-[1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
|
16 |
Alphaprodine |
α-1,3-dimethyl-4-phenyl-4-propionoxypiperidine |
|
17 |
Allylprodine |
3-allyl-1-methyl-4-phenyl-4-propionoxypiperidine |
|
18 |
Anileridine |
1-p-aminophenethyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
|
19 |
Benzethidine |
1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
|
20 |
Benzylmorphine |
3-benzylmorphine |
|
21 |
Betacetylmethadol |
β-3-acetoxy-6-dimethylamino-4,4-diphenylheptane |
|
22 |
Beta-hydroxy-3-methylfentanyl* |
N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl]propionanilide |
|
23 |
Beta-hydroxyfentanyl* |
N-[1-(β-hydroxyphenethyl)-4-piperidyl]propionanilide |
|
24 |
Betameprodine |
β-3-ethyl-1-methyl-4-phenyl-4-propionoxypiperidine |
|
25 |
Betamethadol |
β-6-dimethylamino-4,4-diphenyl-3-heptanol |
|
26 |
Betaprodine |
β-1,3-dimethyl-4-phenyl-4-propionoxypiperidine |
|
27 |
Bezitramide |
1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benz-imidazolinyl)-piperidine |
|
28 |
Brorphine |
1-{1-[1-(4-bromophenyl)ethyl]-piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one |
|
29 |
Butyrfentanyl |
N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]butanamide |
|
30 |
Cannabis*, cannabis resin* and extracts and tinctures of cannabis (Kannabisz*, kannabisz-gyanta*, |
||
31 |
Carfentanil* |
methyl 1-(2-phenylethyl)-4-[phenyl(propanoyl)amino]piperidine-4-carboxylate |
|
32 |
Clonitazene |
2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole |
|
33 |
Coca leaf |
||
34 |
Cocaine |
methyl ester of benzoylecgonine |
|
35 |
Codoxime |
dihydrocodeinone-6-carboxymethyloxime |
|
36 |
Concentrate of poppy straw |
CPS |
A mákszalma alkaloid tartalmának dúsítására irányuló feldolgozás során nyert, kereskedelmi forgalmazásra szánt anyag. |
37 |
Crotonylfentanyl |
(E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide |
|
38 |
Cyclopropylfentanyl |
N-phenyl-N-[1-(2-phenylethyl)piperidin-4- yl]cyclopropanecarboxamide |
|
39 |
Desomorphine* |
dihydrodeoxymorphine |
|
40 |
Dextromoramide |
(+)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)butyl]-morpholine |
|
41 |
Diampromide |
N-[2-(methylphenethylamino)-propyl]propionanilide |
|
42 |
Diethylthiambutene |
3-diethylamino-1,1-di-(2’-thienyl)-1-butene |
|
43 |
Difenoxin |
1-(3-cyano-3,3-diphenylpropyl)-4-phenylisonipecotic acid |
|
44 |
Dihydroetorphine |
7,8-dihydro-7α-[1-(R)-hydroxy-1-methylbutyl]-6,14-endo-ethanotetrahydrooripavine |
|
45 |
Dihydromorphine |
morfinszármazék |
|
46 |
Dimenoxadol |
2-dimethylaminoethyl-1-ethoxy-1,1-diphenylacetate |
|
47 |
Dimepheptanol |
6-dimethylamino-4,4-diphenyl-3-heptanol |
|
48 |
Dimethylthiambutene |
3-dimethylamino-1,1-di-(2’-thienyl)-1-butene |
|
49 |
Dioxaphetyl butyrate |
ethyl-4-morpholino-2,2-diphenylbutyrate |
|
50 |
Diphenoxylate |
1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
|
51 |
Dipipanone |
4,4-diphenyl-6-piperidine-3-heptanone |
|
52 |
Drotebanol |
3,4-dimethoxy-17-methylmorphinan-6β,14-diol |
|
53 |
Ecgonine |
ennek észterei és derivátumai, amelyek ekgoninná és kokainná alakíthatóak |
|
54 |
Ethylmethylthiambutene |
3-ethylmethylamino-1,1-di-(2’-thienyl)-1-butene |
|
55 |
Etonitazene |
1-diethylaminoethyl-2-p-ethoxybenzyl-5-nitrobenzimidazole |
|
56 |
Etorphine* |
tetrahydro-7α-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine |
|
57 |
Etoxeridine |
1-[2-(2-hydroxyethoxy)-ethyl]-4-phenylpiperidine-4-carboxylic acid ethyl ester |
|
58 |
Fentanyl |
1-phenethyl-4-N-propionylanilinopiperidine |
|
59 |
Furanylfentanil |
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]furan-2-carboxamide |
|
60 |
Furethidine |
1-(2-tetrahydrofurfuryloxyethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
|
61 |
Heroin* |
diacetylmorphine |
|
62 |
Hydrocodone |
dihydrocodeinone |
|
63 |
Hydromorphinol |
14-hydroxydihydromorphine |
|
64 |
Hydromorphone |
dihydromorphinone |
|
65 |
Hydroxypethidine |
4-m-hydroxyphenyl-1-methylpiperidine-4-carboxylic acid ethyl ester |
|
66 |
Isomethadone |
6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone |
|
67 |
Isotonitazene |
N,N-diethyl-2-[2-(4-isopropoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl]ethan-1-amine |
|
68 |
Ketobemidone* |
4-m-hydroxyphenyl-1-methyl-4-propionylpiperidine |
|
69 |
Levomethorphan1 |
(-)-3-methoxy-N-methylmorphinan |
|
70 |
Levomoramide |
(-)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)-butyl]morpholine |
|
71 |
Levophenacylmorphan |
(-)-3-hydroxy-N-phenacylmorphinan |
|
72 |
Levorphanol1 |
(-)-3-hydroxy-N-methylmorphinan |
|
73 |
Metazocine |
2’-hydroxy-2,5,9-trimethyl-6,7-benzomorphan |
|
74 |
Methadone |
6-dimethylamino-4,4-diphenyl-3-heptanone |
|
75 |
Methadone intermediate |
4-cyano-2-dimethylamino-4,4-diphenylbutane |
|
76 |
Methoxyacetylfentanyl |
2-methoxy-N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide |
|
77 |
Methyldesorphine |
6-methyl-∆6-deoxymorphine (derivative of morphine) |
|
78 |
Methyldihydromorphine |
6-methyldihydromorphine |
|
79 |
Metonitazene |
N,N-diethyl-2-[2-(4-methoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl]ethan-1-amine |
|
80 |
Metopon |
5-methyldihydromorphinone |
|
81 |
Moramide intermediate |
2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid |
|
82 |
Morpheridine |
1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
|
83 |
Morphine |
az ópium és ópium mák fő alkaloidja |
|
84 |
Morphine methobromide |
morfin-metobromid és egyéb öt vegyértékű nitrogént tartalmazó morfinszármazékok, beleértve a morfin-N-oxid származékokat, amelyek közé tartozik a kodein-N-oxid is |
|
85 |
Morphine-N-oxide |
morfinszármazék |
|
86 |
MPPP* |
1-methyl-4-phenyl-4-piperidinol propionate (ester) |
|
87 |
Myrophine |
myristylbenzylmorphine |
|
88 |
Nicomorphine |
3,6-dinicotinylmorphine |
|
89 |
Noracymethadol |
(±)-α-3-acetoxy-6-methylamino-4,4-diphenylheptane |
|
90 |
Norlevorphanol |
(-)-3-hydroxymorphinan |
|
91 |
Normethadone |
6-dimethylamino-4,4-diphenyl-3-hexanone |
|
92 |
Normorphine |
demethylmorphine |
|
93 |
Norpipanone |
4,4-diphenyl-6-piperidino-3-hexanone |
|
94 |
Ocfentanyl |
N-(2-fluorophenyl)-2-methoxy-N-[1-(2-phenylethyl)piperidin-4-yl]acetamide |
|
95 |
Opium |
||
96 |
Oripavine |
3-O-demethylthebaine |
|
97 |
Orthofluorofentanyl |
N-(2-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide |
|
98 |
Oxycodone |
14-hydroxydihydrocodeinone |
|
99 |
Oxymorphone |
14-hydroxydihydromorphinone |
|
100 |
Parafluorobutyrylfentanyl |
N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide |
|
101 |
Para-fluorofentanyl* |
4’-fluoro-N-(1-phenethyl-4-piperidyl)propionanilide |
|
102 |
PEPAP* |
1-phenethyl-4-phenyl-4-piperidinol acetate (ester) |
|
103 |
Pethidine |
1-methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester |
|
104 |
Pethidine intermediate A |
4-cyano-1-methyl-4-phenylpiperidine |
|
105 |
Pethidine intermediate B |
4-phenylpiperidine-4-carboxylic acid ethyl ester |
|
106 |
Pethidine intermediate C |
1-methyl-4-phenylpiperidine-4-carboxylic acid |
|
107 |
Phenadoxone |
6-morpholino-4,4-diphenyl-3-heptanone |
|
108 |
Phenampromide |
N-(1-methyl-2-piperidinoethyl)propionanilide |
|
109 |
Phenazocine |
2’-hydroxy-5,9-dimethyl-2-phenethyl-6,7-benzomorphan |
|
110 |
Phenomorphan |
3-hydroxy-N-phenethylmorphinan |
|
111 |
Phenoperidine |
1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester |
|
112 |
Piminodine |
4-phenyl-1-(3-phenylaminopropyl)-piperidine-4-carboxylic acid ethyl ester |
|
113 |
Piritramide |
1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide |
|
114 |
Proheptazine |
1,3-dimethyl-4-phenyl-4-propionoxyazacycloheptane |
|
115 |
Properidine |
1-methyl-4-phenylpiperidine-4-carboxylic acid isopropyl ester |
|
116 |
Racemethorphan |
(±)-3-methoxy-N-methylmorphinan |
|
117 |
Racemoramide |
(±)-4-[2-methyl-4-oxo-3,3-diphenyl-4-(1-pyrrolidinyl)-butyl]-morpholine |
|
118 |
Racemorphan |
(±)-3-hydroxy-N-methylmorphinan |
|
119 |
Remifentanil |
1-(2-methoxy-carbonyl-ethyl)-4-(phenyl-N-propionylamino)-piperidine-4-carboxylic acid methyl ester |
|
120 |
Sufentanil |
N-[4-(methoxymethyl)-1-[2-(2-thienyl)-ethyl]-4-piperidyl]propionanilide |
|
121 |
Tetrahydrofuranylfentanyl |
THF-F |
N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide |
122 |
Thebacon |
acetyldihydrocodeinone |
|
123 |
Thebaine |
ópium alkaloid, a Murvás mákban is megtalálható |
|
124 |
Thiofentanyl* |
N-[1-[2-(2-thienyl)ethyl]-4-piperidyl]propionanilide |
|
125 |
Tilidine |
(±)-ethyl-trans-2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate |
|
126 |
Trimeperidine |
1,2,5-trimethyl-4-phenyl-4-propionoxypiperidine |
|
127 |
U-47700 |
3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methyl-benzamide |
|
128 |
Valerylfentanyl |
N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide |
(a továbbiakban: Kábítószer Egyezmény) szerinti aktualizált I. listával.
|
A |
B |
C |
---|---|---|---|
1 |
Hivatalos név |
Más név vagy rövidítés, külföldön gyakran használt írásmód |
Kémiai név / Leírás |
2 |
Acetyldihydrocodeine (acetildihidrokodein) |
kodeinszármazék |
|
3 |
Codeine |
3-methylmorphine |
|
4 |
Dextropropoxyphene |
α-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-butanol propionate |
|
5 |
Dihydrocodeine |
morfinszármazék |
|
6 |
Ethylmorphine |
3-ethylmorphine |
|
7 |
Nicocodine |
6-nicotinylcodeine |
|
8 |
Nicodicodine |
6-nicotinyldihydrocodeine |
|
9 |
Norcodeine |
N-demethylcodeine |
|
10 |
Pholcodine |
morpholinylethylmorphine |
|
11 |
Propiram |
N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide |
2. melléklet a 78/2022. (XII. 28.) BM rendelethez
A pszichotróp anyagok alábbi jegyzékeiben hivatalos elnevezésként a táblázat A oszlopában az INN szerepel. Az angol név vastagon szedve, a magyar név alatta zárójelben található. Ha egy adott vegyületnél vagy anyagnál az INCB által közzétett aktuális listán nem áll rendelkezésre INN, hivatalos névként ezen aktuális listán közzétett első egyéb elnevezés kerül átvezetésre. A táblázat B oszlopában az INCB által közzétett egyéb elnevezések, esetleges más nevek, rövidítések, illetve a külföldön gyakran használt más írásmód kerülnek feltüntetésre, vesszővel elválasztva. A jegyzékek C oszlopában a kémiai név, illetve dőlt betűvel a leírás szerepel.
1. Pszichotróp anyagok 1. jegyzéke (P1 jegyzék)
1.1. Pszichotróp anyagok az alábbi anyagok és vegyületek:
A |
B |
C |
|
---|---|---|---|
1 |
Hivatalos név |
Más név vagy rövidítés, külföldön gyakran használt írásmód |
Kémiai név / Leírás |
2 |
1-naphyrone*** |
1-(naphthalen-1-yl)-2-(pyrrolidin-1-yl)pentan-1-one |
|
3 |
1-PEA*** |
1-amino-1-fenil-etán; 1-fenetil-amin° |
|
4 |
25I-NBOMe |
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine |
|
5 |
2-aminoindane*** |
2,3-dihydro-1H-inden-2-amine |
|
6 |
2C-IEU |
2,5-dimethoxy-4-iodophenethylamineEU2 ; 4-Iod-2,5-dimethoxyphenethylazan°° |
|
7 |
2C-T-2EU |
2,5-dimethoxy-4-ethylthiophenethylamineEU2; |
|
8 |
2C-T-7EU |
2,5-dimetoxi-4-(n)-propil-tio-fenetil-aminEU2; |
|
9 |
2-DPMP*** |
Desoxypipradrol |
2-(diphenylmethyl)piperidine |
10 |
2-naphyrone*** |
1-(naphthalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-one |
|
11 |
3,4-dichloromethylphenidate *** |
3,4-CTMP |
methyl-2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate |
12 |
3,4-methylenedioxypyrovalerone ** |
MDPV |
(RS)-1-(benzo[d][1,3]dioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one |
13 |
3F-phenmetrazine*** |
meta-fluoro-phenmetrazine, meta-F-phenmetrazine |
2-(3-fluorophenyl)-3-methylmorpholine |
14 |
3-MeO-PCE*** |
N-ethyl-1-(3-methoxyphenyl)cyclohexanamine |
|
15 |
3-MeO-PCP** |
3-Methoxyphencyclidine |
1-[1-(3-methoxyphenyl)cyclohexyl]-piperidine |
16 |
4-MAEU |
4-methylamphetamine |
1-(4-methylphenyl)propan-2-amine |
17 |
4-benzylpiperidine*** |
4-(phenylmethyl)piperidine |
|
18 |
4F-MDMB-BICA EU |
methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate |
|
19 |
4-MEC** |
4-methylethcathinone |
2-(ethylamino)-1-(4-methylphenyl)propan-1-one |
20 |
4-MeO-PCP*** |
1-[1-(4-methoxyphenyl)cyclohexyl]piperidine |
|
21 |
4-methylaminorex |
(±)-cis-2-amino-4-methyl-5-phenyl-2-oxazoline |
|
22 |
4-MTA |
α-methyl-4-methylthiophenethylamine |
|
23 |
5F-AB-PINACA*** |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
|
24 |
5-IAI*** |
5-iodo-2,3-dihydro-1H-inden-2-amine |
|
25 |
5-ITEU |
5-(2-aminopropyl)indole |
|
26 |
5-MeO-AMT*** |
1-(5-methoxy-1H-indol-3-yl)propan-2-amine |
|
27 |
A-836,339*** |
N-[3-(2-methoxyethyl)-4,5-dimethyl-1,3-thiazol-2-ylidene]-2,2,3,3-tetramethylcyclopropane-carboxamide |
|
28 |
AH-7921EU |
3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide |
|
29 |
AL*** |
4-allil-oxi-3,5-dimetoxi-fenetil-amin ° |
|
30 |
alpha-PBT*** |
a-PBT, α-Pyrrolidinobutiothiophenone |
2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)butan-1-one |
31 |
alpha-PVP** |
α-pyrrolidinovalerophenone |
1-phenyl-2-(1-pyrrolidinyl)-1-pentanone |
32 |
alpha-PVT*** |
α-PVT, alpha-pyrrolidinopentiothiophenone |
2-(pyrrolidin-1-yl)-1-(thiophen-2-yl)pentan-1-one |
33 |
AM-1248 azepane isomer *** |
adamant-1-yl[1-(1-methylazepan-3-yl)-1H-indol-3-yl] methanone |
|
34 |
AM-2201** |
JWH-2201 |
1-[(5-fluoropentyl)-1H-indol-3-yl]-(naphthalen-1-yl)methanone |
35 |
AMT*** |
1-(1H-indol-3-yl)propan-2-amine |
|
36 |
BDB*** |
1-(1,3-benzo-dioxol-5-il)-2-bután-amin°; 1-(1,3-benzodioxol-5-yl)butan-2-ylazan°° |
|
37 |
Brolamfetamine |
DOB |
(±)-4-bromo-2,5-dimethoxy-α-methylphenethylamine |
38 |
BZPEU |
1-benzilpiperazinEU3; |
|
39 |
β-Me-PEA*** |
2-phenylpropan-1-amine |
|
40 |
Camfetamine*** |
N-methyl-3-phenylbicyclo[2.2.1]heptan-2-amine |
|
41 |
Cathinone |
(-)-(S)-2-amino-propiophenone |
|
42 |
CP 47,497 C8-homológ*** |
2-(3-hydroxycyclohexyl)-5-(2-methylnonan-2-yl)phenol |
|
43 |
CRA 13*** |
naphthalen-1-yl [4-(pentyloxy)naphthalen-1-yl]methanone |
|
44 |
D2PM*** |
Diphenylprolinol |
diphenyl(pyrrolidin-2-yl)methanol |
45 |
DBZP*** |
1,4-dibenzylpiperazine |
|
46 |
Desoxy-D2PM*** |
2-(diphenylmethyl)pyrrolidine |
|
47 |
DET |
3-[2-(diethyl-amino)ethyl]indole |
|
48 |
Dimethocaine*** |
3-(diethylamino)-2,2-dimethylpropyl-4-aminobenzoate |
|
49 |
Diphenidine** |
1,2-diphenylethylpiperidine, DPD, 1,2-DEP, DIPH |
1-(1,2-diphenylethyl)piperidine |
50 |
DMA |
(±)-2,5-dimethoxy-α-methylphenethylamine |
|
51 |
DMAA*** |
4-methylhexan-2-amine |
|
52 |
DMHP |
3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol |
|
53 |
DMT |
3-[2-(dimethylamino)ethyl]indole |
|
54 |
DOC |
4-chloro-2,5-dimethoxyamfetamine; 2,5-dimetoxi-4-klór-amfetamin° |
|
55 |
DOET |
(±)-4-ethyl-2,5-dimethoxy-α-methylphenethylamine |
|
56 |
EG-018*** |
(naphthalen-1-yl)(9-pentyl-9H-carbazol-3-yl)-methanone |
|
57 |
Etaqualone*** |
3-(2-ethylphenyl)-2-methylquinazolin-4(3H)-one |
|
58 |
Eticyclidine |
PCE |
N-ethyl-1-phenylcyclohexylamine |
59 |
Etryptamine |
3-(2-aminobutyl)indole |
|
60 |
FLEA*** |
N-hidroxi-N-metil-3,4-metilén-dioxi-amfetamin; |
|
61 |
GBL*** |
gamma-butyrolactone |
dihydrofuran-2(3H)-one |
62 |
Homoamphetamine*** |
3-amino-1-phenyl-butane |
|
63 |
HU-210*** |
9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol |
|
64 |
Ibogain*** |
(6R,6aS,7S,9R)-7-ethyl-2-methoxy-6,6a,7,8,9,10,12,13-octahydro-5H-6,9-methanopyrido[10,20:1,2]azepino[4,5-b]indole |
|
65 |
JWH-018** |
AM-678 |
naphthalen-1-yl (1-pentyl-1H-indol-3-yl)methanone |
66 |
JWH-073*** |
(1-butyl-1H-indol-3-yl)(naphthalen-1-yl)methanone |
|
67 |
JWH-081*** |
(4-methoxynaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone |
|
68 |
JWH-122*** |
(4-methylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone |
|
69 |
JWH-210*** |
(4-ethylnaphthalen-1-yl)(1-pentyl-1H-indol-3-yl)methanone |
|
70 |
(+)-Lysergide |
LSD, LSD-25 |
9,10-didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide |
71 |
MAL*** |
3,5-dimetoxi-4-metallil-oxi-fenetil-amin°; |
|
72 |
MBDB*** |
2-(metil-amino)-1-(3,4-metilén-dioxi-fenil)-bután vagy N-metil-1-(1,3-benzo-dioxol-5-il)-2-bután-amin°; |
|
73 |
MBZP*** |
1-benzyl-4-methylpiperazine |
|
74 |
mCPP*** |
meta-chlorophenylpiperazine°; |
|
75 |
MDAI*** |
6,7-dihydro-5H-indeno[5,6-d][1,3]dioxol-6-amine |
|
76 |
MDE |
N-ethyl MDA, MDEA |
(±)-N-ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine |
77 |
MDMA |
(±)-N,α-dimethyl-3,4-(methylenedioxy)phenethylamine |
|
78 |
MDMB-CHMICA** |
Methyl 2-{[1-(cyclohexylmethyl)indole-3-carbonyl]amino}-3,3-dimethylbutanoate |
|
79 |
MephedroneEU |
4-methylmethcathinone, 4-methylephedrone, 4-MMC |
(RS)-2-methylamino-1-(4-methylphenyl)propan1-one |
80 |
Mescaline |
3,4,5-trimethoxyphenethylamine |
|
81 |
Methcathinone |
2-(methylamino)-1-phenylpropan-1-one |
|
82 |
Methoxetamine** |
MXE |
(RS)-2-(3-methoxyphenyl)-2-(ethylamino)-cyclohexanone |
83 |
Methylone** |
beta-keto-MDMA |
(RS)-2-methylamino-1-(3,4- |
84 |
Methiopropamine** (metiltienil-propamin) |
MPA, Methylthietnylpropamine |
1-(thiophen-2-yl)-2-methylaminopropane |
85 |
MMDA |
5-methoxy-α-methyl-3,4-(methylenedioxy)phenethylamine |
|
86 |
MT-45EU |
1-cyclohexyl-4-(1,2-diphenylethyl)piperazine |
|
87 |
MTP*** |
methcathinone thiophen analog |
2-(methylamino)-1-(thiophen-2-yl)propan-1-one |
88 |
MTTA*** |
MTA, Mephtetramine |
2-[(methylamino)methyl]-3,4-dihydronaphthalen-1(2H)-one |
89 |
MXP*** |
methoxyphenidine, 2-MeO-diphenidine |
1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine |
90 |
N-(2-methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine*** |
N-(2-methoxyethyl)-N-(1-methylethyl)-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine |
|
91 |
N,N-diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazol- methanamine*** |
N,N-diethyl-2-(1-pentyl-1H-indol-3-yl)-4-thiazol-methanamine |
|
92 |
N-ethylnorketamine*** |
2-(2-chlorophenyl)-2-(ethylamino)cyclohexanone |
|
93 |
N-hydroxy MDA |
(±)-N-[α-methyl-3,4-(methylenedioxy)phenethyl] hydroxylamine |
|
94 |
Nitracaine*** |
3-(diethylamino)-2,2-dimethylpropyl 4-nitrobenzoate |
|
95 |
N-Me-1-PEA*** |
1-(N-metil-amino)-1-fenil-etán; |
|
96 |
ODT*** |
O-desmethyltramadol |
3-{2-[(dimethylamino)methyl]-1-hydroxycyclohexyl}phenol |
97 |
Parahexyl |
3-hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol |
|
98 |
para-Methyl-4-methylaminorex ** |
4,4’-DMAR |
4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine |
99 |
Pentedron** |
β-ethyl-methcathinone (β-etil-metkatinon) |
(±)-2-(methylamino)-1-phenylpentan-1-one |
100 |
pFBT*** |
4-fluorotropacocaine |
8-methyl-8-azabicyclo[3.2.1]oct-3-yl 4-fluorobenzoate |
101 |
pFPP*** |
1-(4-fluorophenyl)piperazine |
|
102 |
Phenazepam** |
7-bromo-5-(2-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
|
103 |
PMA |
1-(4-methoxyphenyl)propan-2-amine |
|
104 |
PMMAEU |
paramethoxymethylamphetamineEU1; |
|
105 |
Psilocine |
Psilotsin |
3-[2-(dimethylamino)ethyl]indol-4-ol |
106 |
Psilocybine |
3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate |
|
107 |
Rolicyclidine |
PHP, PCPY |
1-(1-phenylcyclohexyl)pyrrolidine |
108 |
Salvinorin A*** |
(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester |
|
109 |
STP |
DOM |
2,5-dimethoxy-α,4-dimethylphenethylamine |
110 |
Tenamfetamine |
MDA |
α-methyl-3,4-(methylenedioxy)phenethylamine |
111 |
Tenocyclidine |
TCP |
1-[1-(2-thienyl)cyclohexyl]piperidine |
112 |
Tetrahydrocannabinol, the following isomers and their stereochemical variants |
delta-6a(10a)-THC |
7,8,9,10-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
delta-6a(7)-THC |
(9R, 10aR)-8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo-[b,d]pyran-1-ol |
||
delta-7-THC |
(6aR,9R,10aR)-6a,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
||
delta-8-THC |
(6aR, 10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo-[b,d]pyran-1-ol |
||
delta-10-THC |
6a,7,8,9-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
||
delta-9(11)-THC |
(6aR, 10aR)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
||
113 |
TFMPP*** |
1-[3-(trifluoromethyl)phenyl]piperazine |
|
114 |
TMA |
(±)-3,4,5-trimethoxy-α-methylphenethylamine |
|
115 |
TMA-2EU |
2,4,5-trimethoxyamphetamineEU2; |
|
116 |
3-methylmethcathinone, 3-MMC |
2-(methylamino)-1-(3-methylphenyl)propan-1-one |
|
117 |
3-chloromethcathinone, 3-CMC |
1-(3-chlorophenyl)-2-(methylamino)propan-1-one |
1.2. Ezeken felül a fenti anyagok sztereoizomerjei, ha azok a feltüntetett kémiai névnek megfelelnek, kémiai szerkezetük alapján léteznek és nem esnek kifejezetten kivételes rendelkezés alá, továbbá ezek sói, beleértve sztereoizomerjeik sóit, ha ilyen sók léteznek.
1.3. A P1 jegyzéken az alábbi anyagok kerülnek feltüntetésre:
2. Pszichotróp anyagok 2. jegyzéke (P2 jegyzék)
2.1. Pszichotróp anyagok az alábbi anyagok és vegyületek:
|
A |
B |
C |
---|---|---|---|
1 |
Hivatalos név |
Más név vagy rövidítés, külföldön gyakran használt írásmód |
Kémiai név / Leírás |
2 |
2C-B |
4-bromo-2,5-dimethoxyphenethylamine |
|
3 |
4-CMC |
4-chloromethcathinone, clephedrone |
1-(4-chlorophenyl)-2-(methylamino)-1-propanone |
4 |
4-FA |
4-fluoroamphetamine |
1-(4-fluorophenyl)propan-2-amine |
5 |
4F-MDMB-BINACA |
Methyl (S)-2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate |
|
6 |
5F-AKB-48 |
5F-APINACA |
N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide |
7 |
5F-AMB |
5F-AMB-PINACA, |
Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}amino)-3-methylbutanoate |
8 |
5F-MDMB-PICA |
5F-MDMB-2201 |
Methyl (S)-2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate |
9 |
5F-ADB |
5F-MDMB-PINACA |
Methyl (2S)-2-{[1-(fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate |
10 |
5F-PB-22 |
Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate |
|
11 |
AB-CHMINACA |
N-[(2S)-1-amino-3-methyl-oxobutan-2-yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
|
12 |
AB-FUBINACA |
N-[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]-1-[(4-fluorophenyl)methyl]indazole-3-carboxamide |
|
13 |
AB-PINACA |
N-[(2S)-1-Amino-3-methyl-1-oxobutan-2-yl]-1-pentyl-1H-indazole-3-carboxamide |
|
14 |
ADB-CHMINACA |
MAB-CHMINACA |
N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2- yl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide |
15 |
ADB-FUBINACA |
N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2- yl]-1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxamide |
|
16 |
alpha-PHP |
(RS)-1-phenyl-2-(pyrrolidine-1-yl)hexan-1-one |
|
17 |
Amfetamine |
amphetamine |
(±)-α-methylphenethylamine |
18 |
Amineptine |
7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid |
|
19 |
Buprenorphine** (buprenorfin) |
21-cyclopropyl-7-α-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine |
|
20 |
CUMYL-4CN-BINACA |
1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide |
|
21 |
CUMYL-PEGACLONE |
5-pentyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
|
22 |
Dexamfetamine (dexamfetamin) |
dexamphetamine |
(+)-α-methylphenethylamine |
23 |
Dronabinol2 |
delta-9-tetrahydrocannabinol and its stereochemical variants |
(6aR, 10aR)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol |
24 |
Ethylone |
(RS)-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1- one |
|
25 |
Ethylphenidate (etilfenidát) |
„Nopaine”, „Fake cocaine” |
Ethyl 2-phenyl-2-(piperidin-2-yl)acetate |
26 |
Eutylone (eutilon) |
1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one |
|
27 |
Fenetylline (fenetillin) |
7-{2-[(α-methylphenethyl)amino]ethyl}theophylline |
|
28 |
FUB-AMB |
MMB-FUBINACA, AMB-FUBINACA |
Methyl (2S)-2-({1-[(4-fluorophenyl)methyl]-1H-indazole-3-carbonyl}amino)-3-methylbutanoate |
29 |
gamma-Hydroxybutiric acid (gamma-hidroxi-vajsav) |
GHB |
γ-hydroxybutyric acid |
30 |
Ketamine*** |
2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone |
|
31 |
Levamfetamine (levamfetamin) |
levamphetamine |
(-)-(R)-α-methylphenethylamine |
32 |
Levomethamphetamine (levometamfetamin) |
levomethamphetamine |
(-)-N,α-dimethylphenethylamine |
33 |
MDMB-4en-PINACA |
Methyl 3,3-dimethyl-2-[1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido]butanoate |
|
34 |
Mecloqualone (meklokvalon) |
3-(o-chlorophenyl)-2-methyl-4-(3H)-quinazolinone |
|
35 |
Metamfetamine (metamfetamin) |
metamphetamine |
(+)-(S)-N,α-dimethylphenethylamine |
36 |
Metamfetamine racemate (metamfetamin racemát) |
metamphetamine racemate |
(±)-N,α-dimethylphenethylamine |
37 |
Methaqualone (metakvalon) |
2-methyl-3-o-tolyl-4-(3H)-quinazolinone |
|
38 |
Methylphenidate (metilfenidát) |
Methyl α-phenyl-2-piperidine acetate |
|
39 |
N-ethylhexedrone |
2-(ethylamino)-1-phenyl-1-hexanone |
|
40 |
N-ethyl norpentylone |
ephylone |
1-(2H-1,3-benzodioxol-5-yl)-2-(ethylamino)pentan-1-one |
41 |
Pentazocine** (pentazocin) |
(2R,*6R,*11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol |
|
42 |
Phencyclidine |
PCP |
1-(1-phenylcyclohexyl)piperidine |
43 |
Phenmetrazine |
3-methyl-2-phenylmorpholine |
|
44 |
Poppy straw** |
||
45 |
Secobarbital |
5-allyl-5-(1-methylbutyl)barbituric acid |
|
46 |
Tapentadol *** |
3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]- phenol |
|
47 |
UR-144 |
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone |
|
48 |
XLR-11 |
[1-(5-fluoropentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone |
|
49 |
Zipeprol |
α-(α-methoxybenzyl)-4-(β-methoxyphenethyl)-1-piperazineethanol |
2.2. Ezeken felül a fenti anyagok sztereoizomerjei, ha azok a feltüntetett kémiai névnek megfelelnek, kémiai szerkezetük alapján léteznek és nem esnek kifejezett kivételes rendelkezés alá, továbbá ezek sói, ha ilyen sók léteznek.
2.3. A P2 jegyzéken az alábbi anyagok kerülnek feltüntetésre:
2.3.1. A Pszichotróp Egyezmény szerinti aktualizált II. listán szereplő anyagok,
2.3.2. ** jelöléssel azon anyagok, amelyek nemzeti ellenőrzése a hazai és nemzetközi rendészeti hatósági tapasztalatok alapján szigorúbb, mint a Pszichotróp Egyezmény előírása,
2.3.3. *** jelöléssel azon anyagok, amelyek nemzeti ellenőrzése a hazai és nemzetközi rendészeti hatósági tapasztalatok alapján szigorúbb és nem szerepelnek a Kábítószer Egyezmény és Pszichotróp Egyezmény jegyzékeiben.
2.4. A 2 jellel jelölt anyag esetében a dronabinol megjelölés csak a (-)-trans-delta-9-tetrahydrocannabinol sztereoizomerre vonatkozik.
3. Pszichotróp anyagok 3. jegyzéke (P3 jegyzék)
3.1. Pszichotróp anyagok az alábbi anyagok és vegyületek:
|
A |
B |
C |
---|---|---|---|
1 |
Hivatalos név |
Más név vagy rövidítés, külföldön gyakran használt írásmód |
Kémiai név / Leírás |
2 |
Amobarbital |
5-ethyl-5-isopentylbarbituric acid |
|
3 |
Butalbital |
5-allyl-5-isobutylbarbituric acid |
|
4 |
Cathine |
(+)-norpseudoephedrine |
(+)-(S)-α-[(S)-1-aminoethyl]benzyl alcohol |
5 |
Cyclobarbital |
5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid |
|
6 |
Flunitrazepam |
5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one |
|
7 |
Glutethimide |
2-ethyl-2-phenylglutarimide |
|
8 |
Pentobarbital |
5-ethyl-5-(1-methylbutyl)barbituric acid |
3.2. Ezeken felül a fenti anyagok sztereoizomerjei, ha azok a feltüntetett kémiai névnek megfelelnek, kémiai szerkezetük alapján léteznek és nem esnek kifejezett kivételes rendelkezés alá, továbbá ezek sói, ha ilyen sók léteznek.
3.3. A P3 jegyzék a Pszichotróp Egyezmény aktualizált III. listája alapján készült.
4. Pszichotróp anyagok 4. jegyzéke (P4 jegyzék)
4.1. Pszichotróp anyagok az alábbi anyagok és vegyületek:
|
A |
B |
C |
---|---|---|---|
1 |
Hivatalos név |
Más név vagy rövidítés, külföldön gyakran használt írásmód |
Kémiai név / Leírás |
2 |
Allobarbital |
5,5-diallylbarbituric acid |
|
3 |
Alprazolam |
8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
|
4 |
Amfepramone |
diethylpropion |
2-(diethylamino)propiophenone |
5 |
Aminorex |
2-amino-5-phenyl-2-oxazoline |
|
6 |
Barbital |
5,5-diethylbarbituric acid |
|
7 |
Benzfetamine |
benzphetamine |
N-benzyl-N,α-dimethylphenethylamine |
8 |
Bromazepam |
7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one |
|
9 |
Brotizolam |
2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine |
|
10 |
Butobarbital |
5-butyl-5-ethylbarbituric acid |
|
11 |
Camazepam |
7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one dimethylcarbamate (ester) |
|
12 |
Chlordiazepoxide (klórdiazepoxid) |
7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide |
|
13 |
Clobazam |
7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione |
|
14 |
Clonazepam |
5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one |
|
15 |
Clonazolam |
6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
|
16 |
Clorazepate |
7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid |
|
17 |
Clotiazepam |
5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one |
|
18 |
Cloxazolam |
10-chloro-11b-(o-chlorophenyl)-2,3,7,11b-tetrahydro-oxazolo-[3,2-d][1,4]benzodiazepin-6(5H)-one |
|
19 |
Delorazepam |
7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
|
20 |
Diazepam |
7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one |
|
21 |
Diclazepam |
2-chlorodiazepam, Ro5-3448 |
7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one |
22 |
Estazolam |
8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine |
|
23 |
Ethchlorvynol |
1-chloro-3-ethyl-1-penten-4-yn-3-ol |
|
24 |
Ethinamate |
1-ethynylcyclohexanolcarbamate |
|
25 |
Ethyl loflazepate |
ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate |
|
26 |
Etilamfetamine |
N-ethylamphetamine |
N-ethyl-α-methylphenethylamine |
27 |
Etizolam |
4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
|
28 |
Fencamfamin |
N-ethyl-3-phenyl-2-norbornanamine |
|
29 |
Fenproporex |
(±)-3-[(α-methylphenylethyl)amino]propionitrile |
|
30 |
Flualprazolam |
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepime |
|
31 |
Flubromazolam |
8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine |
|
32 |
Fludiazepam |
7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one |
|
33 |
Flurazepam |
7-chloro-1-[2-(diethylamino)ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
|
34 |
Halazepam |
7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one |
|
35 |
Haloxazolam |
10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one |
|
36 |
Ketazolam |
11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-dione |
|
37 |
Lefetamine |
SPA |
(–)-N,N-dimethyl-1,2-diphenylethylamine |
38 |
Loprazolam |
6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one |
|
39 |
Lorazepam (lorazepám) |
7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one |
|
40 |
Lormetazepam (lormetazepám) |
7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one |
|
41 |
Mazindol |
5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1- a]isoindol-5-ol |
|
42 |
Medazepam (medazepám) |
7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine |
|
43 |
Mefenorex (mefenorex) |
N-(3-chloropropyl)-α-methylphenethylamine |
|
44 |
Meprobamate (meprobamát) |
2-methyl-2-propyl-1,3-propanedioldicarbamate |
|
45 |
Mesocarb |
3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine |
|
46 |
Methylphenobarbital (metilfenobarbitál) |
5-ethyl-1-methyl-5-phenylbarbituric acid |
|
47 |
Methyprylon (metiprilon) |
3,3-diethyl-5-methyl-2,4-piperidine-dione |
|
48 |
Midazolam (midazolám) |
8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine |
|
49 |
Nimetazepam (nimetazepám) |
1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one |
|
50 |
Nitrazepam (nitrazepám) |
1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one |
|
51 |
Nordazepam (nordazepám) |
7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one |
|
52 |
Oxazepam (oxazepám) |
7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one |
|
53 |
Oxazolam (oxazolám) |
10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one |
|
54 |
Pemoline |
2-amino-5-phenyl-2-oxazolin-4-one |
|
55 |
Phendimetrazine (fendimetrazin) |
(+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine |
|
56 |
Phenobarbital (fenobarbitál) |
5-ethyl-5-phenylbarbituric acid |
|
57 |
Phentermine (fentermin) |
α,α-dimethylphenethylamine |
|
58 |
Pinazepam (pinazepám) |
7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin-2-one |
|
59 |
Pipradrol |
1,1-diphenyl-1-(2-piperidyl)methanol |
|
60 |
Prazepam (prazepám) |
7-chloro-1-(cyclopropylmethyl)-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one |
|
61 |
Pyrovalerone (pirovaleron) |
4’-methyl-2-(1-pyrrolidinyl)valerophenone |
|
62 |
Secbutabarbital (szekbutabarbitál) |
5-sec-butyl-5-ethylbarbituric acid |
|
63 |
Temazepam (temazepám) |
7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one |
|
64 |
Tetrazepam (tetrazepám) |
7-chloro-5-(1-cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one |
|
65 |
Triazolam (triazolám) |
8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4] benzodiazepine |
|
66 |
Vinylbital (vinilbitál) |
5-(1-methylbutyl)-5-vinylbarbituric acid |
|
67 |
Zolpidem (zolpidem) |
N,N,6-trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide |
4.2. Ezeken felül a fenti anyagok sztereoizomerjei, ha azok a feltüntetett kémiai névnek megfelelnek, kémiai szerkezetük alapján léteznek és nem esnek kifejezett kivételes rendelkezés alá, továbbá ezek sói, ha ilyen sók léteznek.
4.3. A P4 jegyzék a Pszichotróp Egyezmény aktualizált IV. listája alapján készült.
3. melléklet a 78/2022. (XII. 28.) BM rendelethez
Új pszichoaktív anyagok a következő szerkezeti leírásoknak megfelelő vegyületek, ha azok az 1. és 2. melléklet szerinti jegyzékeken nem szerepelnek:
1. Azok
1.1. az indolil-naftil-keton (1H-indol-3-il(naftalin-1-il)metanon, 1H-indol-3-il(naftalin-2-il)metanon), vagy
1.2. a fenil-indolil-keton (fenil(1H-indol-3-il)metanon) vagy
1.3. a benzil-indolil-keton (2-fenil-1-(1H-indol-3-il)etanon) vagy
1.4. az indazolil-naftil-keton (1H-indazol-3-il(naftalin-1-il)metanon, 1H-indazol-3-il(naftalin-2-il)metanon) vagy
1.5. a fenil-indazolil-keton (fenil(1H-indazol-3-il)metanon) vagy
1.6. a benzil-indazolil-keton (2-fenil-1-(1H-indazol-3-il)etanon) vagy
1.7. a naftil-pirrolil-keton (naftalin-1-il(1H-pirrol-3-il)metanon, naftalin-2-il(1H-pirrol-3-il)metanon) vagy
1.8. a (ciklusos alkil)-indolil-keton (mono- vagy policikloalkil(1H-indol-3-il)metanon) vagy
1.9. a (ciklusos alkil)-indazolil-keton (mono- vagy policikloalkil(1H-indazol-3-il)metanon) vagy
1.10. a (ciklusos alkil)-pirrolil-keton (mono- vagy policikloalkil(1H-pirrol-3-il)metanon) vagy
1.11. az indol-3-karboxilát (1H-indol-3-karbonsav észterszármazék) vagy
1.12. az indol-3-karboxamid (1H-indol-3-karboxamid) vagy
1.13. az indazol-3-karboxilát (1H-indazol-3-karbonsav észterszármazék) vagy
1.14. az indazol-3-karboxamid (1H-indazol-3-karboxamid)
2. Azok a katinon (2-amino-1-fenilpropán-1-on) szerkezeti részt tartalmazó vegyületek, a bupropion, kivételével, amelyekben
2.1. a propán-1-on szerkezeti egység 3-as helyzetű szénatomja
2.1.1. legfeljebb 6 szénatomos alkilcsoportot tartalmazhat,
2.2. a fenilcsoport egy vagy – tetszőleges kombinációban – több
2.2.1. halogénatomot, metil, etil, metoxi, metiléndioxi (metilénbiszoxi-), trimetilén (propán-1,3-diil), etilénoxi-csoportot tartalmazhat,
2.3. a nitrogénatom
2.3.1. 1-4 szénatomos alkilcsoportot vagy alkilcsoportokat tartalmazhat vagy
2.3.2. benzilcsoportot tartalmazhat vagy
2.3.3. pirrolidin vagy piperidin gyűrű tagja.
3. Azok a triptamin (2-(1H-indol-3-il)etánamin) szerkezeti részt tartalmazó vegyületek, amelyekben
3.1. az aminocsoport nitrogénje
3.1.1. legfeljebb 4 szénatomos alkil-, vagy alkenilcsoportot, illetve csoportokat tartalmaz,
3.2. az indolil csoport 4-es vagy 5-ös helyzetben
3.2.1. hidroxi-, metoxi- vagy acetoxicsoportot tartalmazhat.
4. Azok a fenetilamin (2-feniletánamin) szerkezeti részt tartalmazó vegyületek – ideértve a 2-feniletánamint is –, amelyekben
4.1. az aminocsoport egy vagy – tetszőleges kombinációban – több
4.1.1. legfeljebb 4 szénatomos alkil-, alkenil-, cikloalkil-, halogénalkil-, hidroxialkil-, cianoalkil- vagy metoxialkil-csoportot,
4.1.2. acetil-, hidroxi-, metoxi-, ciklopropilmetil-, benzil-, metoxibenzil-, dimetoxibenzil-, trimetoxibenzil-, vagy furilmetil-csoportot tartalmazhat;
4.2. az aminocsoport azetidin, pirrolidin vagy piperidin gyűrű tagja lehet;
4.3. az etánamin szerkezeti rész 1-es helyzetű szénatomja
4.3.1. legfeljebb 4 szénatomos alkilcsoportot tartalmazhat;
4.4. a fenilcsoport egy vagy – tetszőleges kombinációban – több
4.4.1. legfeljebb 5 szénatomos alkil-, (cikloalkil)alkil-, alkoxi-, (cikloalkil)alkoxi-, (alkoxi)alkil-, alkilszulfanil-, alkilamino-, halogénalkil-csoportot, illetve
4.4.2. halogénatomot, benzil-, benziloxi-, amino-, ciano-, nitro-, trimetilén- (propán-1,3 diil), metiléndioxi- (metilénbiszoxi-), etiléndioxi- (etilénbiszoxi-), etilénoxi-, etendiiloxi-, etilénimino- (etilénazandiil-), etendiilimino- (eten-1,2-diilazandiil-) csoportot
5. Azok az N-fenil-1-(2-feniletil)-4-piperidinamin szerkezeti részt tartalmazó vegyületek, amelyekben
5.1. a piperidinamin rész nitrogénatomjához 1-4 szénatomszámú alkil- vagy alkenil- vagy metoxialkil- vagy 3-6 szénatomos cikloalkilcsoportot, illetve furanil- vagy tetrahidrofuranil-csoportot tartalmazó karbonil-rész szénatomja kapcsolódik,
5.2. az N-fenil rész fenilgyűrűjéhez halogén- vagy metoxi-csoport kapcsolódhat,
5.3. a piperidin részhez egy vagy – tetszőleges kombinációban – több metil-, illetve karbometoxi-csoport kapcsolódhat,
5.4. a feniletil rész alifás szénatomjaihoz metil- vagy hidroxi-csoport kapcsolódhat.
6. Az 1–5. pontban foglaltakon túlmenően továbbá
6.1. a következő vegyületek:
|
A |
B |
---|---|---|
1 |
Hivatalos elnevezés (illetve más név vagy rövidítés, |
Kémiai név |
2 |
2C-B-BZP |
1-(4-bromo-2,5-dimethoxybenzyl)-4-methylpiperazine |
3 |
CPCPP, Gelbes |
1-(3-chlorophenyl)-4-(3-chloropropyl)piperazine |
4 |
Dichlorophenyl-piperazine (diklórfenil-piperazin) |
1-(2,3-dichlorophenyl)piperazine |
5 |
Harmin |
7-methoxy-1-methyl-9H-β-carboline |
6 |
5-MeO-triptamin |
2-(5-methoxy-1H-indol-3-yl)ethanamine |
7 |
N-benzyl-1-PEA (N-benzil-1-PEA) |
N-benzyl-1-phenylethanamine |
8 |
pCPP |
1-(4-chlorophenyl)piperazine |
9 |
1-phenyl-propyl-amine (fenilpropilamin) |
1-phenylpropan-1-amine |
10 |
pMeOPP |
1-(4-methoxyphenyl)piperazine |
11 |
URB-754 |
6-methyl-2-[(4-methylphenyl)amino]-1-benzoxazin-4-one |
12 |
RH-34 |
3-[2-(2-methoxybenzylamino)ethyl]-1H-quinazoline-2,4-dione |
13 |
MEOP; Methoxypiperamide; metoxipiperamid; MEXP; 1(4methoxybenzoyl)-4-methylpiperazine |
(4-methoxyphenyl)(4-methylpiperazin-1-yl)methanone |
14 |
bk-2C-B |
2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanone |
15 |
25I-NBF |
2-(4-iodo-2,5-dimethoxyphenyl)- |
16 |
Mexedrone; 4-MMC-oMe; ’MEX’ |
3-methoxy-2-(methylamino)-1-(4-methylphenyl)propan-1-one |
17 |
TH-PVP |
2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl)pentan-1-one |
18 |
izopropilfenidát (isopropylphenidate) |
propan-2-yl phenyl(piperidin-2-yl)acetate |
19 |
metamnetamin (methylnaphetamine; N-methyl- PAL-287; MNT; MNA) |
N-methyl-1-(naphthalen-2-yl)propan-2-amine |
20 |
dezklórketamin (deschloroketamine; |
2-(methylamino)-2-phenylcyclohexanone |
21 |
1P-LSD (1-propionyl-d-lysergic acid diethylamide) |
N,N-diethyl-7-methyl-4-propanoyl-6,6a,8, |
22 |
Ethylnaphthidate; HDEP-28 |
ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate |
23 |
4-methylmethylphenidate; 4Me-TMP |
methyl 2-(piperidin-2-yl)-2-(p-tolyl)acetate |
24 |
4-fluoromethylphenidate; 4F-TMP; 4F-MPH; 4-FMPH |
methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate |
25 |
CUMYL-5F-P7AICA; CUMYL-5F-PAICA; SGT-263 |
1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide |
26 |
(Iso)butyryl-F-fentanyl N-benzyl analogue |
2-methyl-N-(1-benzylpiperidin-4-yl)-N-(4-fluorophenyl)propanamide |
27 |
Despropionyl-2-fluoro fentanyl; despropionyl-o-fluoro fentanyl |
N-(2-fluorophenyl)-1-(2-phenylethyl)piperidin-4-amine |
28 |
Flubromazepam |
7-bromo-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4- |
29 |
5-fluoropentyl-3-pyridinoylindole |
[1-(5-fluoropentyl)-1H-indol-3-yl](pyridin-3-yl)methanone |
30 |
Phenibut |
4-amino-3-phenylbutanoic acid |
31 |
2-fluorodeschloroketamine; 2-Fl-2’-Oxo-PCM; fluoroketamine; 2-FDCK; 2F-DK; 2-FDK; 2-FK |
2-(2-fluorophenyl)-2-(methylamino)cyclohexanone |
32 |
Dichloropane; RTI-111; RTI-4229-111; O-401 |
methyl 3-(3,4-dichlorophenyl)-8-methyl-8- |
33 |
AMAPN |
2-(methylamino)-1-(naphthalen-1-yl)propan-1-one |
34 |
5Cl-bk-MPA; 5Cl-bk-methylthienylpropamine; |
1-(5-chlorothiophen-2-yl)-2-(methylamino)propan-1-one |
35 |
5F-Cumyl-PeGaClone; 5F-SGT-151 |
5-(5-fluoropentyl)-2-(2-phenylpropan-2-yl)-2,5- |
36 |
ALD-52; 1-acetyl-LSD |
(6aR,9R)-4-acetyl-N,N-diethyl-7-methyl- |
37 |
ETH-LAD; 6-ethyl-6-nor-lysergic acid diethylamide |
(6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindolo-[4,3-fg]quinoline-9-carboxamide |
38 |
diphenyl-PBP |
1-(1,3-diphenylpropan-2-yl)pyrrolidine |
39 |
benzoil-fentanil |
1.N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]benzamide; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]benzamide |
40 |
Cumyl-CH-MegaClone |
5-cyclohexylmethyl-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
41 |
1-Aminoindan |
2,3-dihydro-1H-inden-1-amine |
42 |
N-methyl-2AI |
N-methyl-2,3-dihydro-1H-inden-2-amine |
43 |
M-ALPHA |
1-(1,3-benzodioxol-5-yl)-N-methylpropan-1-amine |
44 |
Thiopropamine |
1-(thiophen-2-yl)propan-2-amine |
45 |
2-APB |
1-(1-benzofuran-2-yl)propan-2-amine |
46 |
2-MAPB |
1-(1-benzofuran-2-yl)-N-methylpropan-2-amine |
47 |
2-EAPB |
1-(1-benzofuran-2-yl)-N-ethylpropan-2-amine |
48 |
5-MeO-DIBF |
N-[2-(5-methoxy-1-benzofuran-3-yl)ethyl]-N-(propan-2-yl)propan-2-amine |
49 |
2-MABB |
1-(1-benzofuran-2-yl)-N-methylbutan-2-amine |
50 |
1-(4-Bromo-2,5-dimethoxyphenyl)ethanamine |
1-(4-bromo-2,5-dimethoxyphenyl)ethanamine |
51 |
BOH-PHP |
1-phenyl-2-(pyrrolidin-1-yl)hexan-1-ol |
52 |
2-MeO-Ketamine |
2-(2-methoxyphenyl)-2-(methylamino)cyclohexanone |
53 |
Methoxetamine brominated derivative |
2-(2-bromo-5-methoxyphenyl)-2-(ethylamino)cyclohexanone |
54 |
3MeO-PCMo |
4-[1-(3-methoxyphenyl)cyclohexyl]morpholine |
55 |
Benocyclidine |
1-[1-(benzothiophen-2-yl)cyclohexyl]piperidine |
56 |
Tiletamine |
2-(ethylamino)-2-(2-thienyl)cyclohexanone |
57 |
deschloro-N-ethyl-ketamine (O-PCE) |
2-(ethylamino)-2-phenyl-cyclohexanone |
58 |
3-MeO-PCMMo |
4-{[1-(3-methoxyphenyl)cyclohexyl]methyl}morpholine |
59 |
3-HO-PCE |
3-[1-(ethylamino)cyclohexyl]phenol |
60 |
3-HO-PCP |
3-(1-piperidin-1-ylcyclohexyl)phenol |
61 |
Methoxpropamine |
2-(3-methoxyphenyl)-2-(propylamino)cyclohexan-1-one |
62 |
Pyrazolam |
8-bromo-1-methyl-6-(pyridin-2-yl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine |
63 |
Alprazolam triazolobenzophenone derivative |
{2-[3-(aminomethyl)-5-methyl-4H-1,2,4-triazol-4-yl]-5- |
64 |
Meclonazepam |
5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4- |
65 |
Deschloroetizolam |
2-ethyl-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
66 |
Nifoxipam |
5-(2-fluorophenyl)-3-hydroxy-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
67 |
Adinazolam |
1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4] |
68 |
Metizolam |
4-(2-chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
69 |
Nitrazolam |
1-methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4] |
70 |
Cloniprazepam |
5-(2-chlorophenyl)-1-(cyclopropylmethyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
71 |
Cinazepam |
4-{[7-bromo-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4- benzodiazepin-3-yl]oxy}-4-oxo-butanoic acid |
72 |
3-hydroxyphenazepam |
7-bromo-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4- benzodiazepin-2-one |
73 |
Fonazepam |
5-(2-fluorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one |
74 |
4-chlorodiazepam |
7-chloro-5-(4-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one |
75 |
Flunitrazolam |
6-(2-fluorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine |
76 |
Bromazolam |
8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4] |
77 |
Norfludiazepam |
7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one |
78 |
Ro 07-4065 |
7-chloro-5-(2,6-difluorophenyl)-1-methyl-3H-1,4- |
79 |
Thionordazepam |
7-chloro-5-phenyl-1,3-dihydro-1,4-benzodiazepine-2-thione |
80 |
Methyl clonazepam |
5-(2-chlorophenyl)-1-methyl-7-nitro-3H-1,4-benzodiazepin-2-one |
81 |
Fluclotizolam |
2-chloro-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
82 |
Clobromazolam |
8-bromo-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo |
83 |
Bentazepam |
5-phenyl-1,3,6,7,8,9-hexahydro-2H-[1]benzothieno[2,3-e] |
84 |
CP 47,497 |
5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl] |
85 |
AM-1220 Azepane Isomer |
[1-(hexahydro-1-methyl-1H-azepin-3-yl)-1H-indol-3-yl]-1-naphthalenyl-methanone |
86 |
Org 27569 |
5-chloro-3-ethyl-N-[2-[4-(1-piperidinyl)phenyl]ethyl]-1H-indole-2-carboxamide |
87 |
Org 27759 |
N-[2-[4-(dimethylamino)phenyl]ethyl]-3-ethyl-5-fluoro-1H-indole-2-carboxamide |
88 |
Org 29647 |
N-(1-benzylpyrrolidin-3-yl)-5-chloro-3-ethyl-1H-indole-2-carboxamide |
89 |
HU-331 |
3-hydroxy-2-(6-isopropenyl-3-methyl-cyclohex-2-en-1-yl)-5-pentyl-1,4-benzoquinone |
90 |
WIN 55212-2 |
[(3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalen-1-yl-methanone |
91 |
AB-005 azepane isomer |
[1-(1-methylazepan-2-yl)indol-3-yl]-(2,2,3,3- tetramethylcyclopropyl)methanone |
92 |
4-HTMPIPO |
4-hydroxy-3,3,4-trimethyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-one |
93 |
URB-597 |
3’-carbamoylbiphenyl-3-yl cyclohexylcarbamate |
94 |
JTE-907 |
N-(1,3-benzodioxol-5-ylmethyl)-2-hydroxy-7-methoxy-8-pentoxy-quinoline-3-carboxamide |
95 |
LY2183240 |
5-([1,1’-biphenyl]-4-ylmethyl)-N,N-dimethyl-1H-tetrazole-1-carboxamide |
96 |
1-(Cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-1H-benzimidazol-5-carboxamide |
1-(cyclohexylmethyl)-2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-benzimidazole-5-carboxamide |
97 |
AM-2201 benzimidazole analogue (FUBIMINA) |
[1-(5-fluoropentyl)-1H-benzimidazol-2-yl](naphthalen-1-yl)methanone |
98 |
5F-AB-FUPPYCA (5F-5,3-AB-PFUPPYCA) |
2-{[1-(5-fluoropentyl)-5-(4-fluorophenyl)-1H-pyrazol-3-yl]formamido}-3-methylbutanamide |
99 |
5F-PY-PICA |
[1-(5-fluoropentyl)-1H-indol-3-yl](pyrrolidin-1-yl)methanone |
100 |
5F-PY-PINACA |
[1-(5-fluoropentyl)-1H-indazol-3-yl](pyrrolidin-1-yl)methanone |
101 |
AB-CHMFUPPYCA (3,5-AB-CHMFUPPYCA) |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-3-(4-fluorophenyl)-1H-pyrazole- |
102 |
MDMB-CHMCZCA |
9-(cyclohexylmethyl)-N-(1-methoxycarbonyl- |
103 |
5F-PCN |
1-(5-fluoropentyl)-N-(naphthalen-1-yl)-1H-pyrrolo[3,2-c] |
104 |
EG-2201 |
[9-(5-fluoropentyl)-9H-carbazol-3-yl](naphthalen- |
105 |
MDA 19 |
N-[(Z)-(1-hexyl-2-oxo-indolin-3-ylidene)amino]benzamide |
106 |
MO-CHMINACA |
1-methoxy-3,3-dimethyl-1-oxobutan-2-yl |
107 |
MDMB-PCZCA |
methyl 3,3-dimethyl-2-[(9-pentylcarbazole-3-carbonyl)amino] butanoate |
108 |
5F-3,5-AB-PFUPPYCA |
N-(1-carbamoyl-2-methyl-propyl)-1-(5-fluoropentyl)-3-(4- fluorophenyl)pyrazole-5-carboxamide |
109 |
CUMYL-4CN-B7AICA |
1-(4-cyanobutyl)-N-(1-methyl-1-phenyl-ethyl)pyrrolo[2,3-b]pyridine-3-carboxamide |
110 |
5F-MDMB-P4AICA |
methyl 2-{[1-(5-fluoropentyl)pyrrolo[3,2-b]pyridine- |
111 |
5F-MDMB-P7AICA |
methyl 2-{[1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]formamido}-3,3-dimethylbutanoate |
112 |
5F-AB-P7AICA |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)- |
113 |
2F-QMPSB |
quinolin-8-yl 3-[(4,4-difluoropiperidin-1-yl) |
114 |
5F-A-P7AICA |
N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-pyrrolo[2,3-b] |
115 |
3’,4’-Methylenedioxy-alpha-methylPPP (MDMPP) |
1-(1,3-benzodioxol-5-yl)-2-methyl-2-(pyrrolidin-1-yl) |
116 |
1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidinyl-1-yl)ethan-1-one |
1-(2,3-dihydro-1H-inden-5-yl)-2-phenyl-2-(pyrrolidin- |
117 |
alpha-PPP-MeO |
3-methoxy-1-phenyl-2-(pyrrolidin-1-yl)propan-1-one |
118 |
3,4-Dichloro-N,N-cyclohexylmethylmethcathinone |
2-[cyclohexyl(methyl)amino]-1-(3,4-dichlorophenyl)propan-1-one |
119 |
TH-PBP |
2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaphthalen-2-yl) |
120 |
alpha-pyrrolidinocyclohexylphenone (alpha-PCYP) |
2-cyclohexyl-1-phenyl-2-(pyrrolidin-1-yl)ethan-1-one |
121 |
2-Me-DMT |
N,N-dimethyl-2-(2-methyl-1H-indol-3-yl)ethanamine |
122 |
AL-LAD |
(8β)-9,10-didehydro-N,N-diethyl-6-(2-propenyl)-ergoline- |
123 |
McPT |
N-[2-(1H-indol-3-yl)ethyl]-N-methylcyclopropanamine |
124 |
alpha-TMT |
1-(1H-indol-3-yl)-N,N-dimethylpropan-2-amine |
125 |
1P-ETH-LAD |
N,N,7-triethyl-4-propanoyl-6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide |
126 |
5-MeO-pyr-T |
5-methoxy-3-(2-pyrrolidin-1-ylethyl)-1H-indole |
127 |
Lysergic acid methyl ester |
methyl 7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg] |
128 |
4-HO-McPT |
3-{2-[cyclopropyl(methyl)amino]ethyl}-1H-indol-4-ol |
129 |
4-PrO-DMT |
3-[2-(dimethylamino)ethyl]-1H-indol-4-yl propanoate |
130 |
Butorphanol |
17-(cyclobutylmethyl)morphinan-3,14-diol |
131 |
U-49900 |
3,4-dichloro-N-[2-(diethylamino)cyclohexyl]- |
132 |
U-51754 |
2-(3,4-dichlorophenyl)-N-[2-(dimethylamino)cyclohexyl]-N-methyl-acetamide |
133 |
Benzodioxole-fentanyl |
N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]-1,3-benzodioxole-5-carboxamide |
134 |
3-phenylpropanoylfentanyl |
N,3-diphenyl-N-[1-(2-phenylethyl)-4-piperidyl]propanamide |
135 |
Tetramethylcyclopropanefentanyl |
2,2,3,3-tetramethyl-N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl]cyclopropanecarboxamide |
136 |
U-48800 |
2-(2,4-dichlorophenyl)-N-[2-(dimethylamino) |
137 |
Thiophenefentanyl |
N-phenyl-N-[1-(2-phenylethyl)-4-piperidyl] |
138 |
Benzylfentanyl |
N-(1-benzyl-4-piperidyl)-N-phenyl-propanamide |
139 |
Bromadoline |
4-bromo-N-[2-(dimethylamino)cyclohexyl]benzamide |
140 |
Acetylbenzylfentanyl |
N-(1-benzyl-4-piperidyl)-N-phenyl-acetamide |
141 |
Benzoylbenzylfentanyl |
N-(1-benzyl-4-piperidyl)-N-phenyl-benzamide |
142 |
4-hydroxybutyrfentanyl; 4-HO-BF |
N-(4-hydroxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl] |
143 |
isopropyl-U-47700 |
3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-(propan-2-yl)benzamide |
144 |
U-50488 |
2-(3,4-dichlorophenyl)-N-methyl-N-(2-pyrrolidin- |
145 |
3,4-methylenedioxy-U-47700 |
N-[2-(dimethylamino)cyclohexyl]-N-methyl-1,3-benzodioxole-5-carboxamide |
146 |
4-fluoro-cyclopropylbenzylfentanyl |
N-(1-benzyl-4-piperidyl)-N-(4-fluorophenyl) |
147 |
Furanylbenzylfentanyl |
N-(1-benzyl-4-piperidyl)-N-phenyl-furan-2-carboxamide |
148 |
2-methylacetylfentanyl |
N-(2-methylphenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]- |
149 |
N-methyl U-47931E |
4-bromo-N-[2-(dimethylamino)cyclohexyl]- |
150 |
Piperidylthiambutene |
1-[4,4-di(thiophen-2-yl)but-3-en-2-yl]piperidine |
151 |
2-methyl-AP-237 |
1-[2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl] |
152 |
AP-237 |
1-[4-(3-phenylprop-2-en-1-yl)piperazin-1-yl]butan-1-one |
153 |
Furanyl UF-17 |
N-[2-(dimethylamino)cyclohexyl]-N-phenyl-furan- |
154 |
2F-viminol |
2-[di(butan-2-yl)amino]-1-[1-(2-fluorobenzyl)-1H-pyrrol-2-yl]ethan-1-ol |
156 |
Iso-ethcathinone |
1-(ethylamino)-1-phenylpropan-2-one |
157 |
5-HTP |
2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid |
158 |
Ostarine |
3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide |
159 |
4-Fluoroephedrine |
4-fluoro-α-[1-(methylamino)ethyl]-benzenemethanol |
160 |
4-methylphendimetrazine |
3,4-dimethyl-2-(4-methylphenyl)morpholine |
161 |
Mebroqualone |
3-(2-bromophenyl)-2-methylquinazolin-4(3H)-one |
162 |
W-15 |
4-chloro-N-[(2E)-1-(2-phenylethyl)piperidin-2-ylidene] |
163 |
sibutramine |
1-[1-(4-chlorophenyl)cyclobutyl]-N,N,3-trimethyl-butan- |
164 |
Embutramide |
N-[2-ethyl-2-(3-methoxyphenyl)butyl]-4-hydroxybutanamide |
165 |
Lysergic acid 2,4-dimethylazetidide (LSZ) |
[(6aS,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo |
166 |
Noopept |
ethyl ({[(2S)-1-(phenylacetyl)pyrrolidin-2-yl]carbonyl}amino)acetate |
167 |
Mesembrine |
3a-(3,4-dimethoxyphenyl)- |
168 |
Orphenadrine |
N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine |
169 |
Ephenidine (NEDPA) |
N-ethyl-1,2-diphenylethanamine |
170 |
NPDPA |
N-(1,2-diphenylethyl)propan-2-amine |
171 |
W-18 |
4-chloro-N-{(2E)-1-[2-(4-nitrophenyl)ethyl]piperidin- |
172 |
Adrafinil |
2-[(diphenylmethyl)sulfinyl]-N-hydroxy-acetamide |
173 |
Afloqualone |
6-amino-2-(fluoromethyl)-3-(2-methylphenyl)quinazolin- |
174 |
Modafiendz |
2-{[bis(4-fluorophenyl)methyl]sulfinyl}-N-methylacetamide |
175 |
Methylmethaqualone |
3-(2,4-dimethylphenyl)-2-methylquinazolin-4(3H)-one |
176 |
Flibanserin |
1,3-dihydro-1-(2-{4-[3-(trifluoromethyl)phenyl]-1-piperazinyl}ethyl)-2H-benzimidazol-2-one |
177 |
4-methylpentan-2-amine (DMBA) |
4-methylpentan-2-amine |
178 |
Modafinil sulphone |
2-[(diphenylmethyl)sulfonyl]acetamide |
179 |
N-methyl aminorex derivative |
3-methyl-5-phenyl-oxazolidin-2-imine |
180 |
3,4-DMAR |
3,4-dimethyl-5-phenyl-1,3-oxazolidin-2-imine |
181 |
4-MPH |
3-methyl-2-(4-methylphenyl)morpholine |
182 |
Phenetrazine |
3-ethyl-2-phenylmorpholine |
183 |
Epirocaine |
2-methyl-2-(propylamino)propyl benzoate |
184 |
Modafinil |
2-[(diphenylmethyl)sulfinyl]acetamide |
185 |
Iso-phenmetrazine |
5-methyl-2-phenylmorpholine |
186 |
Phenmetetrazine |
4-ethyl-3-methyl-2-phenylmorpholine |
187 |
3F-Phenetrazine |
3-ethyl-2-(3-fluorophenyl)morpholine |
188 |
Bromantane |
N-(4-bromophenyl)tricyclo[3.3.1.13,7]decan-2-amine |
189 |
Viloxazine |
2-[(2-ethoxyphenoxy)methyl]morpholine |
190 |
Fladrafinil |
2-{[bis(4-fluorophenyl)methyl]sulfinyl}-N-hydroxyacetamide |
191 |
PDM-35 |
3,5-dimethyl-2-phenylmorpholine |
192 |
3,6-DMPM |
3,6-dimethyl-2-phenylmorpholine |
193 |
3-methylphenmetrazine |
3-methyl-2-(3-methylphenyl)morpholine |
194 |
G-130 |
5,5-dimethyl-2-phenyl-morpholine |
195 |
Methylmorphenate |
methyl 2-(morpholin-3-yl)-2-phenylacetate |
196 |
PRE-084 |
2-(morpholin-4-yl)ethyl 1-phenylcyclohexane-1-carboxylate |
197 |
NDTDI |
N,N-diethyl-3-{methyl-[(4R)-1,3,4,5-tetrahydrobenzo[c,d]indol-4-yl]amino}propanamide |
198 |
Ru-28306 |
N,N-dimethyl-1,3,4,5-tetrahydrobenzo[c,d]indol-4-amine |
199 |
Octodrine |
6-methylheptan-2-amine |
200 |
1,4-DMAA |
5-methylhexan-2-amine |
201 |
2F-Phenmetrazine |
2-(2-fluorophenyl)-3-methylmorpholine |
202 |
Troparil |
methyl 8-methyl-3-phenyl-8-azabicyclo[3.2.1]octane-4-carboxylate |
203 |
N-methyl-cyclazodone |
2-[cyclopropyl(methyl)amino]-5-phenyl-4(5H)-oxazolon |
204 |
para-fluoro-4-methylaminorex; 4-FPO |
5-(4-fluorophenyl)-4-methyl-4,5-dihydro-1,3-oxazol-2-amine |
205 |
Bisfluoromodafinil |
2-{[bis(4-fluorophenyl)methyl]sulfinyl}acetamide |
206 |
WIN 35428 |
methyl 3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1] |
207 |
alpha-methylephedrine |
3-(methylamino)-2-phenylbutan-2-ol |
208 |
N-methylephedrine |
2-(dimethylamino)-1-phenylpropan-1-ol |
209 |
1B-LSD |
4-butyryl-N,N-diethyl-7-methyl-4,6,6a,7,8,9- |
210 |
2C-B aminorex |
5-(4-bromo-2,5-dimethoxy-phenyl)-4,5-dihydrooxazol- |
211 |
Pagoclone |
2-(7-chloro-1,8-naphthyridin-2-yl)-2,3-dihydro-3- |
212 |
4-fluorophenibut |
4-amino-3-(4-fluorophenyl)butanoic acid |
213 |
Pregabalin methyl ester |
methyl 3-(aminomethyl)-5-methylhexanoate |
214 |
Xylazine |
N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine |
215 |
SL-164 |
5-chloro-3-(4-chloro-2-methylphenyl)-2-methyl-4(3H)- |
216 |
1cP-LSD |
4-(cyclopropanecarbonyl)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide |
217 |
Nitromethaqualone |
3-(2-methoxy-4-nitrophenyl)-2-methylquinazolin-4-one |
218 |
Nefiracetam |
N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide |
219 |
4-Hydroxyamphetamine |
4-(2-aminopropyl)phenol |
220 |
25I-NBMD |
N-(1,3-benzodioxol-4-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine |
221 |
25I-NB34MD |
N-(1,3-benzodioxol-5-ylmethyl)-2-(4-iodo-2,5-dimethoxyphenyl)ethanamine |
222 |
25C-NBF |
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-fluorobenzyl)ethanamine |
223 |
25C-NBOH |
2-({[2-(4-chloro-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol |
224 |
25I-NBOH |
2-{[2-(4-iodo-2,5-dimethoxy-phenyl)ethylamino]methyl}phenol |
225 |
25B-NBF |
2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-fluorophenyl)methyl]ethanamine |
226 |
25B-NBOH |
2-{[2-(4-bromo-2,5-dimethoxy- |
227 |
1-phenethyl-4-hydroxypiperidine |
1-(2-phenylethyl)piperidin-4-ol |
228 |
7-CDMeOPPAE |
7-(2-{[2-(4-chloro-2,5-dimethoxy-phenyl)-1-methyl- |
229 |
25E-NBOH |
2-({[2-(4-ethyl-2,5-dimethoxyphenyl)ethyl]amino}methyl)phenol |
230 |
BOD |
2-(2,5-dimethoxy-4-methylphenyl)-2-methoxyethan-1-amine |
231 |
Vanoxerine |
1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine |
232 |
1-(3-Methylbenzyl)piperazine |
1-(3-methylbenzyl)piperazine |
233 |
NSI-189 |
(4-benzylpiperazin-1-yl)-[2-(isopentylamino)-3- |
234 |
DB-MDBP |
1-[(2,2-difluoro-1,3-benzodioxol-5-yl)methyl]piperazine |
235 |
3,4-CFP |
1-(3-chloro-4-fluorophenyl)piperazine |
236 |
pBPP |
1-(4-bromophenyl)piperazine |
237 |
HDMP-28 (methylnaphthidate) |
methyl naphthalen-2-yl(piperidin-2-yl)acetate |
238 |
Propylphenidate |
propyl phenyl(piperidin-2-yl)acetate |
239 |
4-fluoroethylphenidate |
ethyl 2-(4-fluorophenyl)-2-(2-piperidyl)acetate |
240 |
methyl 2-phenyl-2-(pyrrolidin-1-yl)acetate |
methyl 2-phenyl-2-(pyrrolidin-1-yl)acetate |
241 |
Glaucine |
1,2,9,10-tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H- |
242 |
LSA |
(6aS,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg] |
243 |
Arecoline |
methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate |
244 |
5-Br-DMT |
[2-(5-bromo-1H-indol-3-yl)ethyl]dimethylamine |
245 |
5-Cl-DMT |
[2-(5-chloro-1H-indol-3-yl)ethyl]dimethylamine |
246 |
Mephedrene |
N-methyl-1-(5-methyl-2-thiophenyl)propan-2-amine |
247 |
PTI-3 |
N-({2-[1-(5-fluoropentyl)-1H-indol-3-yl]-1,3-thiazol-4- |
248 |
Cumyl-Cb-MeGaClone |
5-(cyclobutylmethyl)-2-(1-methyl-1-phenyl-ethyl)pyrido |
249 |
BOH-2C-B |
2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethanol |
250 |
N-methylbenzedrone |
2-[benzyl(methyl)amino]-1-(4-methylphenyl)propan-1-one |
251 |
3F-PCP |
1-[1-(3-fluorophenyl)cyclohexyl]piperidine |
252 |
3-Cl-PCP |
1‐[1‐(3‐chlorophenyl)cyclohexyl]piperidine |
253 |
A-D2PV |
1,2-diphenyl-2-(pyrrolidin-1-yl)ethan-1-one |
254 |
3-Me-PCP |
1-[1-(3-methylphenyl)cyclohexyl]piperidine |
255 |
MXiPR |
2-(isopropylamino)-2-(3-methoxyphenyl)-cyclohexanone |
256 |
Cumyl-BC-HpMeGaClone-221 |
5-(bicyclo[2.2.1]hept-2-ylmethyl)-2-(2-phenylpropan-2-yl)-2,5-dihydro-1H-pyrido[4,3-b]indol-1-one |
257 |
3-Methoxyphenmetrazine |
2-(3-methoxyphenyl)-3-methylmorpholine |
258 |
butonitazene |
2-[2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl]-N,N-diethylethan-1-amine |
259 |
etonitazepyne |
2-(4-ethoxybenzyl)-5-nitro-1-[2-(pyrrolidin-1-yl)ethyl]-1H-benzimidazole |
260 |
BDMT |
2,2’-(1H,1’H-[2,2’-biindole]-3,3’-diyl)bis(N,N-dimethylethan-1-amine) |
261 |
ABO-4en-PINACA |
N-(1-amino-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide |
262 |
4F-deprenyl |
N-[1-(4-fluorophenyl)propan-2-yl]-N-methylprop-2-yn-1-amine |
263 |
fluonitazene |
N,N-diethyl-2-[2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl]ethan-1-amine |
264 |
M-alpha-HCMA |
3-(1,3-benzodioxol-5-yl)-2-hydroxy-N,2-dimethyl-3- |
265 |
AP-238 |
1-[2,6-dimethyl-4-(3-phenylprop-2-enyl)piperazin-1-yl]propan-1-one |
266 |
carbonyl-bromadol |
(4-bromophenyl)-[1-(dimethylamino)-4-hydroxy-4- |
267 |
O-AMKD |
3-(4-acetyl-1-methylpiperidin-4-yl)phenyl acetate |
268 |
nortilidine |
ethyl 2-methylamino-1-phenylcyclohex-3-ene-1-carboxylate |
269 |
4,4-dimethyl-1-phenyl-1-pyrrolidin-1-yl-pentan-3-one |
4,4-dimethyl-1-phenyl-1-pyrrolidin-1-yl-pentan-3-one |
270 |
phenylpiracetam |
2-(2-oxo-4-phenylpyrrolidin-1-yl)acetamide |
271 |
deoxymethoxetamine |
2-(ethylamino)-2-(3-methylphenyl)-cyclohexanone |
272 |
CHM-MDMB-CHMINACA |
cyclohexylmethyl 2-[1-(cyclohexylmethyl)-1H-indazole-3- |
273 |
protonitazene |
N,N-diethyl-5-nitro-2-[(4-propoxyphenyl)methyl]-1H- |
274 |
4Br-MAR |
5‐(4‐bromophenyl)‐4‐methyl‐4,5‐dihydro‐1,3‐oxazol‐2‐amine |
275 |
4Cl-MAR |
5‐(4‐chlorophenyl)‐4‐methyl‐4,5‐dihydro‐1,3‐oxazol‐2‐amine |
276 |
2C-T-21 |
2-[4-(2-fluoroethylsulfanyl)-2,5-dimethoxy-phenyl]ethanamine |
277 |
5-chloro-alpha MT |
1‐(5‐chloro‐1H‐indol‐3‐yl)propan‐2‐amine |
278 |
3-chlorophenmetrazine; 3-CPM |
2-(3-chlorophenyl)-3-methylmorpholine |
279 |
hydroxetamine; HXE |
2-(ethylamino)-2-(3-hydroxyphenyl)-cyclohexanone |
280 |
dipyanone |
4,4-diphenyl-6-(pyrrolidin-1-yl)heptan-3-one |
281 |
bretazenil |
1,1-dimethylethyl 8-bromo-11,12,13,13a-tetrahydro-9-oxo- |
282 |
deschloroclotizolam |
2-chloro-9-methyl-4-phenyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine |
283 |
BZO-POXIZID |
N-[(Z)-(2-oxo-1-pentyl-indolin-3-ylidene)amino]benzamide |
284 |
iso-3-CMC |
1-(3-chlorophenyl)-1-(methylamino)propan-2-one |
285 |
BZO-4en-POXIZID |
N-[(Z)-(2-oxo-1-pent-4-enyl-indolin-3-ylidene)amino]benzamide |
286 |
ADB-5Br-INACA |
5-bromo-N-(1-carbamoyl-2,2-dimethyl-propyl)-1H-indazole-3-carboxamide |
287 |
BZO-ChMOXIZID |
N-{(Z)-[1-(cyclohexylmethyl)-2-oxo-indolin-3-ylidene]amino}benzamide |
288 |
3,5-ADB-4en-PFUPPYCA |
N-(1-carbamoyl-2,2-dimethyl-propyl)-3-(4-fluorophenyl)-1-pent-4-enyl-pyrazole-5-carboxamide |
289 |
desmethylmoramide |
4-(4-morpholinyl)-2,2-diphenyl-1-(1-pyrrolidinyl)-1-butanone |
290 |
ADB-FUBIATA |
2-[(2-{1-[(4-fluorophenyl)methyl]indol-3-yl}acetyl) |
291 |
5F-BZO-POXIZID; |
N-{(Z)-[1-(5-fluoropentyl)-2-oxo-indolin-3- |
292 |
3-Me-PCPy |
1-[1-(3-methylphenyl)cyclohexyl]pyrrolidine |
293 |
flubrotizolam |
2-bromo-4-(2-fluorophenyl)-9-methyl-6H-thieno |
294 |
5,3-ADB-4en-PFUPPYCA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-(4-fluorophenyl)-1-pent-4-enyl-pyrazole-3-carboxamide |
295 |
5,3-AB-CHMFUPPYCA |
N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-5-(4-fluorophenyl)-1H-pyrazole-3-carboxamide |
296 |
fenozolone |
2-(ethylamino)-5-phenyl-4(5H)-oxazolone |
297 |
CUMYL-TsINACA |
N-(2-phenylpropan-2-yl)-1-tosyl-1H-indazole-3-carboxamide |
298 |
1V-LSD |
N,N-diethyl-7-methyl-4-pentanoyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide |
299 |
etonitazepipne |
2-(4-ethoxybenzyl)-5-nitro-1-[2-(piperidin-1-yl)ethyl]- |
300 |
iso-(meta-methyl-propcathinone) |
1-(3-methylphenyl)-1-(propylamino)propan-2-one |
301 |
N-benzyl-isopropylamine |
N-benzylpropan-2-amine |
302 |
ADB-IACA (ADB-IATA) |
2-[2-(1H-indol-3-yl)acetamido]-3,3-dimethylbutanamide |
303 |
Cumyl-INACA |
N-(1-methyl-1-phenyl-ethyl)-1H-indazole-3-carboxamide |
304 |
Cumyl-CHSINACA |
1-(cyclohexylsulfonyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide |
305 |
Cumyl-CLCHSINACA |
1-(1-chlorocyclohexyl)sulfonyl-N-(1-methyl-1-phenyl- |
306 |
CH-FUBIACA |
N-cyclohexyl-2-[1-(4-fluorobenzyl)-1H-indol-3-yl]acetamide |
307 |
CH-PIACA |
N-cyclohexyl-2-(1-pentyl-1H-indol-3-yl)acetamide |
308 |
MDMB-5Br-INACA |
methyl 2-(5-bromo-1H-indazole-3-carboxamido)-3,3- |
309 |
ADB-D-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-bromo-1- |
310 |
A-PONASA |
N-(adamantan-1-yl)-4-(pentyloxy)naphthalene-1- |
311 |
fluetizolam |
2-ethyl-4-(2-fluorophenyl)-9-methyl-6H-thieno[3,2- |
312 |
ADB-4en-P-5Br-INACA |
N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-5-bromo-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide |
313 |
desalkylgidazepam |
7-bromo-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one |
314 |
N-cyclohexyl methylone |
1-(1,3-benzodioxol-5-yl)-2-(cyclohexylamino)propan-1-one |
315 |
N-ethyl zolpidem |
N-ethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide |
316 |
2-fluoro-deschloro-N-ethylketamine |
2-(ethylamino)-2-(2-fluorophenyl)cyclohexanone |
317 |
A-FUBIACA |
N-(1-adamantyl)-2-[1-[(4-fluorophenyl)methyl]indol-3-yl]acetamide |
6.2. az ebben a jegyzékben felsorolt anyagok sztereoizomerjei, ha kémiai szerkezetük alapján azok léteznek,
6.3. az ebben a jegyzékben felsorolt anyagok sói, beleértve a 6.2. pontban említett sztereoizomerek sóit, ha ilyen sók léteznek.
A 4. § a 2010. évi CXXX. törvény 12. § (2) bekezdése alapján hatályát vesztette.
Az 5. § a 2010. évi CXXX. törvény 12. § (2) bekezdése alapján hatályát vesztette.
A 6. § a 2010. évi CXXX. törvény 12. § (2) bekezdése alapján hatályát vesztette.
A 7. § a 2010. évi CXXX. törvény 12. § (2) bekezdése alapján hatályát vesztette.
- Hatályos
- Már nem hatályos
- Még nem hatályos
- Módosulni fog
- Időállapotok
- Adott napon hatályos
- Közlönyállapot
- Indokolás